Document is current
Any future updates will be listed below
-
Authors
El-Mallakh, Rif S. https://orcid.org/0000-0002-4992-8016
Doroodgar, Masoud
Elsayed, Omar H.
Kidambi, Neil
- License Information
-
More Information
Article History
Received: 3 August 2022
Revised: 14 January 2023
Accepted: 21 April 2023
First Online: 16 June 2023
Competing interests
: RSE receives grant funding from Sunovion, and is a speaker for Axsome, Intracellular, Janssen, Lundbeck, Noven, Otsuka, and Teva. The other authors declare no competing interests.
